search for




 

Report on the Role of Pharmacist in Communicable Disease Isolation Unit of a Tertiary Teaching Hospital
J. Kor. Soc. Health-syst. Pharm. 2021;38:331-341
Published online August 31, 2021;  https://doi.org/10.32429/jkshp.2021.38.3.004
© 2021 Korean Society of Health-System Pharmacists

Hyo Jung Parka,b†, You Min Sohna,b, Ok Soon Jeongc, Jae-Hyun Leea, Eun Yong Jeona, Yong Seok Leea, Myung Sook Mina, Jae-Hoon Kod, Chi Ryang Chunge, Chi-Min Parke

Department of Pharmaceutical Services, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Koreaa
Sungkyunkwan University School of Pharmacy, 2066 Seobu-ro, Jangan-gu, Suwon-si, Gyeonggi-do, 16419, Republic of Koreab
Department for data service, Samsung Medical Center, Seoul, Republic of Koreac
Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Seoul, Republic of Koread
Department of Critical Care Medicine, Samsung Medical Center,Sungkyunkwan University School of Medicine, Seoul, Republic of Koreae
Correspondence to: 박효정 Tel:02-3410-6091 E-mail:hyoj.park@samsung.com
Received June 15, 2021; Revised July 25, 2021; Accepted July 22, 2021.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background : Due to the COVID-19 pandemic, the importance of monitoring antimicrobial use is increasing. The role of pharmacists for personalized medication considering the latest drug information and patient clinical conditions is very important. So far, no Korean research has reported the role of pharmacists participating as a member of multidisciplinary team in communicable disease isolation units (CDIU) during the novel infectious disease pandemic.
Methods : Clinical data with personal information deleted were reviewed retrospectively. The role of clinical pharmacists in infectious diseases was examined by analyzing pharmaceutical services provided by clinical pharmacists at a CDIU in a tertiary teaching hospital.
Results : Key pharmaceutical services provided by clinical pharmacist had five categories: evidence-based treatment, clinical pathway development, drug formula and shortage management, multidisciplinary team member, and prospective evaluation of drug therapy.
Conclusion : This report confirmed the role of pharmacists having a good understanding of drug treatment as essential members in the multidisciplinary team. It is meaningful in that we report the possibility of expanding clinical pharmacists’ professional functions in Korea for the first time.
Keywords : COVID-19, CDIU, Pharmacist


August 2021, 38 (3)